REFERENCES
- Alles , G. A. 1957 . “ Some relations between chemical structure and physiological action of mescaline and related compounds. ” . In Neuropharmacology Edited by: Abramson , H. A. New York : Josiah Macy, Jr. Foundation. .
- Butler , D. E. , Nordin , I. C. , L'ltalien , Y. J. , Zweisler , L. , Poschel , P. H. and Marriot , J. G. 1984 . Amnesia-reversal activity of a series of N-[(disubstituted amino)alkyl]-2-oxo-1-pyrrolidine acetamides, including pramiracetam . Journal of Medicinal Chemistry , Vol. 27 : 684 – 691 .
- Butler , D. E. , Poschel , B. P. H. and Marriot , J. G. 1981 . Cognition-activating properties of 3-(aryloxy)pyridines . Journal of Medicinal Chemistry , Vol. 24 : 346 – 350 .
- Cole , J. O. 1977 . Research barriers in psychopharmacology . American Journal of Psychiatry , Vol. 134 : 896 – 898 .
- De Felice , S. L. 1972 . Drug Discovery, The Pending Crisis. New York : Medcom. .
- Di Leo , F. 1985 . Personal communication
- Giurgea , C. 1972 . Vers une pharmacologie de I'activité integrative du cerveau. Tentative du concept nootrope en psychopharmacologie . Actualities Pharmacologiques , Vol. 25 : 115 – 156 .
- Lehmann , H. E. 1977 . “ Drugs of the future. ” . In Psychotherapeutic Drugs. Part II. Applications. Edited by: Usdin , E. and Forrest , I. S. New York : Marcel Dekker. .
- Muller-Oerlinghausen , B. 1978 . Ethical problems in clinical psychopharmacology . International Journal of Clinical Pharmacology , Vol. 16 : 433 – 450 .
- Sternbach , L. H. 1979 . The benzodiazepine story . Journal of Medicinal Chemistry , Vol. 22 : 1 – 7 .
- Swazey , J. P. 1974 . Chlorpromazine in Psychiatry. A Study of Therapeutic Innovation. Cambridge , Massachusetts : MIT Press. .
- Wikler , D. 1978 . The central ethical problem in human experimentation and three solutions . Clinical Research , Vol. 26 : 380 – 383 .